EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Immune Response to Chitosan- graft -poly(caprolactone) Biopolymer Scaffolds

Matthew J Moore iD, Yuen Ting Lam, Miguel Santos, Richard P Tan iD, Nianji Yang, Juichien Hung, Zihao Li iD, Kristopher A Kilian iD, Jelena Rnjak-Kovacina iD, Johannes B Pitts, Henning Menzel iD, Steven G Wise iD

ACS Biomaterials Science & Engineering · 12.06.2023 · 9 (6) · 3320-3334

DOI: 10.1021/acsbiomaterials.3c00553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 23.05.2023. Verfasst von Matthew J Moore und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Health and Medicine, The University of Sydney, Camperdown, New South Wales 2006, Australia. Hauptthemen laut MEDLINE: Chitosan. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Health and Medical Research Council, Deutsche Forschungsgemeinschaft, NSW Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomimetic scaffolds recreating key elements of the architecture and biological activity of the extracellular matrix have enormous potential for soft tissue engineering applications. Combining appropriate mechanical properties with select biological cues presents a challenge for bioengineering, as natural materials are most bioactive but can lack mechanical integrity, while synthetic polymers have strength but are often biologically inert. Blends of synthetic and natural materials, aiming to combine the benefits of each, have shown promise but inherently require a compromise, diluting down favorable properties in each polymer to accommodate the other. Here, we electrospun a material comprising chitosan, a natural polysaccharide, and polycaprolactone (PCL), one of the most widely studied synthetic polymers used in materials engineering. In contrast to a classical blend, here PCL was chemically grafted onto the chitosan backbone to create chitosan-graft-polycaprolactone (CS-g-PCL) and then combined further with unmodified PCL to generate scaffolds with discreet chitosan functionalization. These small amounts of chitosan led to significant changes in scaffold architecture and surface chemistry, reducing the fiber diameter, pore size, and hydrophobicity. Interestingly, all CS-g-PCL-containing blends were stronger than control PCL, though with reduced elongation. In in vitro assessments, increasing the CS-g-PCL content led to significant improvements in in vitro blood compatibility compared to PCL alone while increasing fibroblast attachment and proliferation. In a mouse subcutaneous implantation model, a higher CS-g-PCL content improved the immune response to the implants. Macrophages in tissues surrounding CS-g-PCL scaffolds decreased proportionately to the chitosan content by up to 65%, with a corresponding decrease in pro-inflammatory cytokines. These results suggest that CS-g-PCL is a promising hybrid material comprising natural and synthetic polymers with tailorable mechanical and biological properties, justifying further development and in vivo evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanMiceAnimalsTissue ScaffoldsPolymersImmunityPolyesters

Stichwörter der Autor:innen

cell compatibilitychitosanelectrospinningforeign body responsepolycaprolactone

Substanzen

ChitosanPolymerspolycaprolactonePolyesters

Autor:innen und Institutionen

  • School of Medical Sciences, Faculty of Health and Medicine, The University of Sydney, Camperdown, New South Wales 2006, Australia.
  • Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2006, Australia.
  • School of Chemistry, Australian Centre for NanoMedicine, UNSW, Sydney, New South Wales 2052, Australia.
  • Graduate School of Biomedical Engineering, UNSW Australia, Sydney, New South Wales 2052, Australia.
  • Technische Universität Braunschweig, Institute for Technical Chemistry, Braunschweig 38106, Germany.
  • The University of Sydney Nano Institute, The University of Sydney, Camperdown, New South Wales 2006, Australia.

ORCID-Profile: Matthew J Moore, Richard P Tan, Zihao Li, Kristopher A Kilian, Jelena Rnjak-Kovacina, Henning Menzel, Steven G Wise

Förderung

  • National Health and Medical Research Council
  • Deutsche Forschungsgemeinschaft
  • NSW Health
  • Australian Government
  • National Heart Foundation of Australia
  • Sydney Local Health District

Zitieren

APA

Moore, M. J., Lam, Y. T., Santos, M., Tan, R. P., Yang, N., Hung, J., Li, Z., Kilian, K. A., Rnjak-Kovacina, J., Pitts, J. B., Menzel, H., & Wise, S. G. (2023). Evaluation of the Immune Response to Chitosan- graft -poly(caprolactone) Biopolymer Scaffolds. ACS Biomaterials Science & Engineering, 9(6), 3320-3334. https://doi.org/10.1021/acsbiomaterials.3c00553

Vancouver

Moore MJ, Lam YT, Santos M, Tan RP, Yang N, Hung J, et al. Evaluation of the Immune Response to Chitosan- graft -poly(caprolactone) Biopolymer Scaffolds. ACS Biomaterials Science & Engineering. 2023;9(6):3320-3334. doi:10.1021/acsbiomaterials.3c00553

BibTeX
@article{Moore2023,
  author = {Moore, Matthew J and Lam, Yuen Ting and Santos, Miguel and Tan, Richard P and Yang, Nianji and Hung, Juichien and Li, Zihao and Kilian, Kristopher A and Rnjak-Kovacina, Jelena and Pitts, Johannes B and Menzel, Henning and Wise, Steven G},
  title = {Evaluation of the Immune Response to Chitosan- graft -poly(caprolactone) Biopolymer Scaffolds},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2023},
  volume = {9},
  number = {6},
  pages = {3320--3334},
  doi = {10.1021/acsbiomaterials.3c00553}
}
Kostenlos starten →